As antimicrobial-resistant infections are set to overtake cancer as the top global health risk by 2050, the world needs to quickly find a solution that will help in detecting and reducing its risk of mortality while bringing down the economic cost.<\/p>\n
During the keynote session, \"Digital Transformation of Health Care: Intelligent Anti-Microbial System (iAMS),\" at HIMSS22 APAC, Dr Der-Yang Cho, professor and superintendent of China Medical University Hospital, emphasised the importance of developing a new generation of antibiotics using emerging technologies.<\/p>\n
\"Antimicrobial stewardship and development of a next-generation of antibiotics are very important and very critical,\" he said, noting that AMRs claim 4.7 million lives in Asia each year.<\/p>\n
He noted from his presentation that drug-resistant infections lead to more extended hospital stays and potentially greater complications with mortality rising by 7.6% for every hour of delay in administering treatment. Unfortunately, he said, 30%-50% of existing antibiotics are inappropriately prescribed.<\/p>\n
Moreover, there have been no new registered classes of antibiotics for human treatment for over four decades, Dr Cho mentioned.<\/p>\n
In this regard, CMUH developed the Intelligent Anti-Microbial System (iAMS) which integrates four platforms into one. Two platforms on the information side are a clinical decision support system and personalised antibiograms, which shows the antimicrobial susceptibility profile of a targeted microorganism. On the AI-powered risk prediction side is the MALDI-TOF mass spectrometry which predicts both antimicrobial susceptibility of a bacteria and risks of sepsis and mortality.<\/p>\n
\"We put them together into one platform for automating the antimicrobial treatment,\" explained Dr Cho.<\/p>\n
The AI technology has a current accuracy of over 80% and has brought down reporting time from 72 hours to an hour.<\/p>\n
<\/p>\n
Read this article:<\/p>\n
Using AI to fight drug-resistant infections - Healthcare IT News<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" As antimicrobial-resistant infections are set to overtake cancer as the top global health risk by 2050, the world needs to quickly find a solution that will help in detecting and reducing its risk of mortality while bringing down the economic cost. During the keynote session, \"Digital Transformation of Health Care: Intelligent Anti-Microbial System (iAMS),\" at HIMSS22 APAC, Dr Der-Yang Cho, professor and superintendent of China Medical University Hospital, emphasised the importance of developing a new generation of antibiotics using emerging technologies. Continue reading